NVCR Novocure Ltd

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.

$186.75  +4.74 (2.60%)
As of 05/11/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  Jersey
IPO date:  10/02/2015
Outstanding shares:  103,413,367
Average volume:  1,807,927
Market cap:   $19,901,902,479
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G6674U108
ISIN:        JE00BYSS4X48
Sedol:      BYSS4X4
Valuation   (See tab for details)
PE ratio:   1,604.91
PB ratio:   50.47
PS ratio:   37.75
Return on equity:   3.15%
Net income %:   2.22%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy